Issue of New Warrants

Capital Change Notice

Updated as at June 2023

Please do not amend or delete individual rows. As this template relates to prescribed content, changes to content
should only be made where it is clearly indicated that this is permitted, otherwise, if an Issuer considers a particular
element does not apply, mark the row as N/A, Any other changes to this prescribed form must first be approved by
NZX as required under NZX Listing Rule 3.26.1.

Section 1: Issuer information
Name of issuer Promisia Healthcare Limited
NZX ticker code PHLWA
Class of financial product Warrants
ISIN (If unknown, check on NZX website) NZPHLE0002S3
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 9,450,000,000 Warrants
Nominal value (if any) N/A
Issue/acquisition/redemption price per security The Warrants have been
issued for no cash
consideration
Nature of the payment (for example, cash or other
consideration)
The non-cash consideration for
the Warrants was participating
in the share purchase plan and
placements offer announced
on 2 July 2024 (Offer). For
every share allotted under the
Offer, 2 Warrants have been
issued to the participants.
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

200%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
Exercise: Any time on or
before the Expiry Date.
Expiry Date: 24 March 2027
Exercise Price: $0.001
Ranking: Any ordinary shares
issued on the exercise of the
Warrants will rank equally in all
respects with all other ordinary
shares on issue in PHL.
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Issue of Warrants in
connection with PHL’s Offer
announced on 2 July 2024.

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
14,175,000,000
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
NZX Listing Rule 4.2.1 and
Board Resolutions.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The Warrants are issued in
accordance with the terms set
out in the Warrant Terms of
Issue (as varied by
shareholders and warrant
holders on 25 September
2024).
Date of issue/acquisition/redemption
2
26/09/24
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Francisco Rodriguez Ferrere
Contact person for this announcement Francisco Rodriguez Ferrere
Contact phone number 021 245 1801
Contact email address info@promisia.co.nz
Date of release through MAP

26/09/24




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).